Danwei Huangfu
Affiliations: | Developmental Biology | Sloan-Kettering Institute, New York, NY, United States |
Area:
Stem cells, development, regenerationWebsite:
http://www.mskcc.org/research/lab/danwei-huangfuGoogle:
"Danwei Huangfu"Parents
Sign in to add mentorKathryn V. Anderson | grad student | 2005 | Weill Cornell Medical College | |
(Cilia and Hedgehog signaling during mouse development.) | ||||
Douglas A. Melton | post-doc | 2005-2010 | Harvard |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rosen BP, Li QV, Cho H, et al. (2023) Parallel genome-scale CRISPR screens distinguish pluripotency and self-renewal. Biorxiv : the Preprint Server For Biology |
Chen T, Alcorn H, Devbhandari S, et al. (2022) A hypomorphic mutation in Pold1 disrupts the coordination of embryo size expansion and morphogenesis during gastrulation. Biology Open. 11 |
Vanoli F, Meskauskaite B, Herviou L, et al. (2021) Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors. Oncogene |
Huangfu D, García-García MJ, Eggenschwiler J. (2021) Kathryn Anderson (1952-2020). Developmental Cell. 56: 257-259 |
Beer MA, Shigaki D, Huangfu D. (2020) Enhancer Predictions and Genome-Wide Regulatory Circuits. Annual Review of Genomics and Human Genetics |
Vardhana SA, Arnold PK, Rosen BP, et al. (2019) Glutamine independence is a selectable feature of pluripotent stem cells. Nature Metabolism. 1: 676-687 |
Li QV, Rosen BP, Huangfu D. (2019) Decoding pluripotency: Genetic screens to interrogate the acquisition, maintenance, and exit of pluripotency. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. e1464 |
Lee K, Cho H, Rickert RW, et al. (2019) FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation. Cell Reports. 28: 382-393.e7 |
Li QV, Dixon G, Verma N, et al. (2019) Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiation. Nature Genetics |
Amin S, Cook B, Zhou T, et al. (2018) Discovery of a drug candidate for GLIS3-associated diabetes. Nature Communications. 9: 2681 |